Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts-Reference-Cited by-同舟云学术

Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts

Published:2017-04 Issue: Volume:391 Page:1-11
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Luo Tingting,Sun Jiangchuan,Zhu Shenyin,He Juan,Hao Lan,Xiao Linlin,Zhu Yi,Wang Qianqian,Pan Xin,Wang Zhigang,Chang Shufang

Funder

Natural Science Foundation of China

Health and Family Planning Commission Foundation of Chongqing

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J. Clin.,2013

2. Update on first-line treatment of advanced ovarian carcinoma;Kemp;Int. J. Womens Health,2013

3. Stage IV ovarian cancer: disease site-specific rationale for postoperative treatment;Aletti;Gynecol. Oncol.,2009

4. Race in ovarian cancer treatment and survival: a systematic review with meta-analysis;Terplan;Cancer Causes Control,2009

5. New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential;Banerjee;Clin. Cancer Res.,2013

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasound-induced immune responses in tumors: A systematic review and meta-analysis;Journal of Controlled Release;2024-07

2. NanoBubble-Mediated Oxygenation: Elucidating the Underlying Molecular Mechanisms in Hypoxia and Mitochondrial-Related Pathologies;Nanomaterials;2023-11-30

3. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers;Cancer Immunology, Immunotherapy;2023-10-05

4. Recent advances in micro-sized oxygen carriers inspired by red blood cells;Science and Technology of Advanced Materials;2023-06-22

5. Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy;Pharmaceutics;2023-05-30